Among STAT family members, STAT3 is the most well-studied member; it is overexpressed in the majority of human cancers, and targeting STAT3 signaling has been recognized as a potential strategy for treating cancer owing to its roles in tumor formation, metastasis, and drug resistance [9, 10]. The gene discussed is STAT3; the disease is neoplasm.